Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2003 3
2004 1
2007 3
2008 3
2009 3
2010 5
2011 4
2012 6
2013 5
2014 5
2015 4
2016 3
2017 1
2018 2
2019 1
2020 3
2021 4
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Editorial: Methods in cancer genetics.
D'Aguanno S, Buczkowicz P. D'Aguanno S, et al. Front Oncol. 2023 Jul 4;13:1227854. doi: 10.3389/fonc.2023.1227854. eCollection 2023. Front Oncol. 2023. PMID: 37469406 Free PMC article. No abstract available.
Hypoxia-dependent drivers of melanoma progression.
D'Aguanno S, Mallone F, Marenco M, Del Bufalo D, Moramarco A. D'Aguanno S, et al. J Exp Clin Cancer Res. 2021 May 8;40(1):159. doi: 10.1186/s13046-021-01926-6. J Exp Clin Cancer Res. 2021. PMID: 33964953 Free PMC article. Review.
Bcl-2 family inhibitors sensitize human cancer models to therapy.
Valentini E, Di Martile M, Brignone M, Di Caprio M, Manni I, Chiappa M, Sergio I, Chiacchiarini M, Bazzichetto C, Conciatori F, D'Aguanno S, D'Angelo C, Ragno R, Russillo M, Colotti G, Marchesi F, Bellone ML, Dal Piaz F, Felli MP, Damia G, Del Bufalo D. Valentini E, et al. Among authors: d aguanno s. Cell Death Dis. 2023 Jul 17;14(7):441. doi: 10.1038/s41419-023-05963-1. Cell Death Dis. 2023. PMID: 37460459 Free PMC article.
BCL-XL overexpression promotes tumor progression-associated properties.
Trisciuoglio D, Tupone MG, Desideri M, Di Martile M, Gabellini C, Buglioni S, Pallocca M, Alessandrini G, D'Aguanno S, Del Bufalo D. Trisciuoglio D, et al. Among authors: d aguanno s. Cell Death Dis. 2017 Dec 13;8(12):3216. doi: 10.1038/s41419-017-0055-y. Cell Death Dis. 2017. PMID: 29238043 Free PMC article.
Bcl-2-like protein-10 increases aggressive features of melanoma cells.
Del Bufalo D, Di Martile M, Valentini E, Manni I, Masi I, D'Amore A, Filippini A, Nicoletti C, Zaccarini M, Cota C, Castro MV, Quezada MJ, Rosanò L, Lopez-Bergami P, D'Aguanno S. Del Bufalo D, et al. Among authors: d aguanno s. Explor Target Antitumor Ther. 2022;3(1):11-26. doi: 10.37349/etat.2022.00068. Epub 2022 Jan 30. Explor Target Antitumor Ther. 2022. PMID: 36046354 Free PMC article.
Do the smoking intensity and duration, the years since quitting, the methodological quality and the year of publication of the studies affect the results of the meta-analysis on cigarette smoking and Acute Myeloid Leukemia (AML) in adults?
Colamesta V, D'Aguanno S, Breccia M, Bruffa S, Cartoni C, La Torre G. Colamesta V, et al. Among authors: d aguanno s. Crit Rev Oncol Hematol. 2016 Mar;99:376-88. doi: 10.1016/j.critrevonc.2016.01.003. Epub 2016 Jan 15. Crit Rev Oncol Hematol. 2016. PMID: 26830008 Review.
Proteasome inhibitors therapeutic strategies for cancer.
D'Alessandro A, Pieroni L, Ronci M, D'Aguanno S, Federici G, Urbani A. D'Alessandro A, et al. Among authors: d aguanno s. Recent Pat Anticancer Drug Discov. 2009 Jan;4(1):73-82. doi: 10.2174/157489209787002452. Recent Pat Anticancer Drug Discov. 2009. PMID: 19149689 Review.
52 results